Terms: = Uterine cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Treatment
6093 results:
1. Assessing the influence of the health system on access to cervical cancer prevention, screening, and treatment services at public health centers in Addis Ababa, Ethiopia.
Hussein K; Kokwaro G; Wafula F; Kassie GM
PLoS One; 2024; 19(5):e0300152. PubMed ID: 38820249
[TBL] [Abstract] [Full Text] [Related]
2. Provision of cervical cancer services for women living with HIV, Uganda.
Kalamya JN; DeCuir J; Alger SX; Ninsiima J; Kabanda J; Komakech P; Lubega M; Nantege G; Birabwa E; Nyombi TN; Namukanja P; Baveewo S; Ssendiwala J; Calnan J; Mwangi C; Nakawuka M; Mutungi G; Nelson LJ; Dirlikov E
Bull World Health Organ; 2024 Jun; 102(6):382-388. PubMed ID: 38812805
[TBL] [Abstract] [Full Text] [Related]
3. METTL3's role in cervical cancer development through m
Liu Y; Li C; Deng Q; Ren X; Wang H
FASEB J; 2024 Jun; 38(11):e23693. PubMed ID: 38809685
[TBL] [Abstract] [Full Text] [Related]
4. Enhanced cervical precancerous lesions detection and classification using Archimedes Optimization Algorithm with transfer learning.
Allogmani AS; Mohamed RM; Al-Shibly NM; Ragab M
Sci Rep; 2024 May; 14(1):12076. PubMed ID: 38802525
[TBL] [Abstract] [Full Text] [Related]
5. Cervical cancer: Part I human papilloma virus vaccination in Taiwan.
Yang ST; Wang PH; Liu HH; Chang WH; Chou FW; Lee WL
Taiwan J Obstet Gynecol; 2024 May; 63(3):320-328. PubMed ID: 38802194
[TBL] [Abstract] [Full Text] [Related]
6. Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
Broshkevitch CJ; Barnabas RV; Liu G; Palanee-Phillips T; Rao DW
PLoS One; 2024; 19(5):e0301997. PubMed ID: 38781268
[TBL] [Abstract] [Full Text] [Related]
7. KIF23 promotes cervical cancer progression via inhibiting NLRP3-mediated pyroptosis.
Liu X; Xie X; Li Q; Xie X; Xiong M; Han W; Xie W
FASEB J; 2024 May; 38(10):e23685. PubMed ID: 38780518
[TBL] [Abstract] [Full Text] [Related]
8. M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.
Hou PX; Fan Q; Zhang Q; Liu JJ; Wu Q
Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13868. PubMed ID: 38745265
[TBL] [Abstract] [Full Text] [Related]
9. The antitumoral effect of the esculetin in HeLa cells through endoplasmic reticulum stress.
Sahin G; Duran T; Afsar S; Kebapcilar A; Celik C
Eur Rev Med Pharmacol Sci; 2024 Apr; 28(8):3048-3055. PubMed ID: 38708463
[TBL] [Abstract] [Full Text] [Related]
10. Metformin for endometrial hyperplasia.
Shiwani H; Clement NS; Daniels JP; Atiomo W
Cochrane Database Syst Rev; 2024 May; 5(5):CD012214. PubMed ID: 38695827
[TBL] [Abstract] [Full Text] [Related]
11. In Vitro Antiviral and Anticancer Effects of Tanacetum sinaicum Essential Oil on Human Cervical and Breast cancer.
Sheashea AA; Ahmed FA; El Zayat E; Ebeed BW; Elberry MH; Hassan ZKM; Hafez MM
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1457-1471. PubMed ID: 38680008
[TBL] [Abstract] [Full Text] [Related]
12. Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancer.
Eiro N; Fraile M; Escudero-Cernuda S; Sendon-Lago J; Gonzalez LO; Fernandez-Sánchez ML; Vizoso FJ
Stem Cell Res Ther; 2024 Apr; 15(1):121. PubMed ID: 38664697
[TBL] [Abstract] [Full Text] [Related]
13. Exploring TLR signaling pathways as promising targets in cervical cancer: The road less traveled.
Agarwal M; Kumar M; Pathak R; Bala K; Kumar A
Int Rev Cell Mol Biol; 2024; 385():227-261. PubMed ID: 38663961
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of programmed death-ligand 1 expression in adenocarcinoma and squamous cell carcinoma of the cervix in paraffin blocks of patients with cervical cancer.
Hosseini MS; Shafizadeh F; Bahremani MH; Farzaneh F; Ashrafganjoei T; Arab M; Talayeh M; Jafari F; Abdshah A
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2057. PubMed ID: 38662366
[TBL] [Abstract] [Full Text] [Related]
15. Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.
Fackler MJ; Pleas M; Li Y; Soni A; Xing D; Cope L; Ali S; Van Le Q; Van Nguyen C; Pham HT; Duong LM; Vanden Berg E; Wadee R; Michelow P; Chen WC; Joffe M; Fjeldbo CS; Lyng H; Sukumar S
Clin Epigenetics; 2024 Apr; 16(1):56. PubMed ID: 38643219
[TBL] [Abstract] [Full Text] [Related]
16. The role of NF-κB in carcinogenesis of cervical cancer: opportunities and challenges.
Deng S; Yuan P; Sun J
Mol Biol Rep; 2024 Apr; 51(1):538. PubMed ID: 38642209
[TBL] [Abstract] [Full Text] [Related]
17. [Cognition of human papillomavirus and its influencing factors among college students in Shandong province].
Zhang J; Shao SY; Ma YJ; Qin W
Zhonghua Nan Ke Xue; 2023 Sep; 29(9):826-830. PubMed ID: 38639596
[TBL] [Abstract] [Full Text] [Related]
18. Interferon-γ-induced GBP1 is an inhibitor of human papillomavirus 18.
Xu M; Lin MC; Li ZH
BMC Womens Health; 2024 Apr; 24(1):240. PubMed ID: 38622605
[TBL] [Abstract] [Full Text] [Related]
19. TIE1 promotes cervical cancer progression via Basigin-matrix metalloproteinase axis.
Liu P; Xie L; Wu Q; Huang L; Liu X; Li W; Cai J; Wang Z; Yang P; Cai L
Int J Biol Sci; 2024; 20(6):2297-2309. PubMed ID: 38617545
[No Abstract] [Full Text] [Related]
20. Reevaluation of negative cervical conizations: Frequency, diagnostic errors, risk factors and management.
Lorenset LC; Percicote AP; Munhos SHO; Zanine RM
Pathol Res Pract; 2024 May; 257():155283. PubMed ID: 38614053
[TBL] [Abstract] [Full Text] [Related]
[Next]
